Biotech is blazing higher. One technician says it should continue to be a healthy trade.
div > div.group > p:first-child"> The IBB biotechnology ETF is on track for its best quarter in six years, adding 19 percent in a rally twice as steep as the gains on the XLV health care ETF.
"For a lot of investors, they're trying to play catch-up at this point in time, and they're going to continue to play these risk assets," Johnson said Friday on CNBC's"Trading Nation.""We still see decent upside from here to go — perhaps about 6 percent higher from here, maybe as high as 13 percent higher.""One of the names that looks pretty good to us is Regeneron," Johnson said.
John Petrides, portfolio manager at Point View Wealth Manager, has a different pick for biotech stock ready to race higher.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Trump, Kim begin talks with one-on-one meetingHANOI, Vietnam (AP) — President Donald Trump and North Korean leader Kim Jong Un are beginning the second day of their high-stakes nuclear summit with a one-on-one discussion. Trump and Kim...
Leer más »
Lyft is using a controversial new stock structure in its IPO that will let its founders keep 'significant control' of the companyOne share for one vote is no longer the case among tech unicorns who go public.
Leer más »
What could trigger a stock plunge of 5% in one day: Hedge-fund manager Doug KassOur call of the day from Doug Kass, president of Seabreeze Partners Management, warns that we’ve swung from a market opportunity in December to “market vulnerability,” and offers 10 things that could trigger an abrupt 5% drop in stocks.
Leer más »
Here’s what hedge-fund manager Doug Kass foresees triggering a one-day stock plunge of 5%Our call of the day from Doug Kass, president of Seabreeze Partners Management, warns that we’ve swung from a market opportunity in December to “market vulnerability,” and offers 10 things that could trigger an abrupt 5% drop in stocks.
Leer más »
Fed’s Bostic Expects One Rate Rise This Year, Another in 2020Atlanta Fed leader Raphael Bostic is still on board with more central bank interest rate increases, including one this year and one next year, he said in an interview with The Wall Street Journal.
Leer más »